Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+3.4%
5Y CAGR+10.8%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+3.4%/yr
vs +61.4%/yr prior
5Y CAGR
+10.8%/yr
Recent deceleration
Acceleration
-58.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.76B | +2144.1% |
| 2024 | $-232.90M | -106.1% |
| 2023 | $3.83B | -11.0% |
| 2022 | $4.31B | +54.8% |
| 2021 | $2.78B | -2.6% |
| 2020 | $2.86B | +138.5% |
| 2019 | $1.20B | +88.5% |
| 2018 | $635.15M | +415.4% |
| 2017 | $123.24M | +1140.4% |
| 2016 | $9.94M | - |